Gastrointestinal Oncology

Gastric cancer is an belligerent disease that continues to have a formidable  impact on global health. Despite an overall decline in incidence over the last several decades, gastric cancer remains the fourth most common type of cancer and is the second leading cause of cancer-related death worldwide accounting for 10% of global cancer mortalities. Despite the progress made in recent years, the prognosis for patients with advanced-stage GC remains poor. The last several decades have demonstrated a gradual decline in the rates of gastric cancer in most populations and across subtypes. However, whereas most gastric tumors are declining in incidence, tumors of the gastric cardia and gastroesophageal junction are becoming more frequent and there is a trend of rising incidence of noncardia gastric cancer among Americans between 25 and 39 years of age and in the same age group in other western countries. The incidence rate in men is double that of women and incidence increases with age. 

  • Esophageal cancer
  • Stomach cancer
  • Pancreatic Cancer
  • Liver cancer
  • Gallbladder cancer
  • Colorectal Cancer
  • Anal cancer
  • Gastrointestinal carcinoid tumor

Related Conference of Gastrointestinal Oncology

August 03-04, 2026

21st Euro-Global Gastroenterology Conference

London, UK
September 07-08, 2026

26th International Conference on Gastroenterology and Hepatology

Edinburgh, Scotland
September 23-24, 2026

21th European Gastroenterology and Therapeutics Congress

Barcelona, Spain
September 29-30, 2026

7th Global Summit on Earth Science and Climate Change

Paris, France
June 24-25, 2027

15th World Gastro Summit

Paris, France

Gastrointestinal Oncology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in